[glenn1919]

EAF...............................https://stockcharts.com/h-sc/ui?s=EAF&p=W&b=5&g=0&id=p86431144783

[glenn1919]

eaf...............................https://stockcharts.com/h-sc/ui?s=eaf&p=W&b=5&g=0&id=p86431144783

[glenn1919]

eaf..............................https://stockcharts.com/h-sc/ui?s=eaf&p=W&b=5&g=0&id=p86431144783

[glenn1919]

EAF.....................................https://stockcharts.com/h-sc/ui?s=EAF&p=W&b=5&g=0&id=p86431144783

[glenn1919]

EAF............................https://stockcharts.com/h-sc/ui?s=EAF&p=W&b=5&g=0&id=p86431144783

[glenn1919]

EAF,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://stockcharts.com/h-sc/ui?s=EAF&p=W&b=5&g=0&id=p86431144783

[glenn1919]

EAF.............................................https://stockcharts.com/h-sc/ui?s=EAF&p=W&b=5&g=0&id=p86431144783

[glenn1919]

EAF...............https://stockcharts.com/h-sc/ui?s=EAF&p=W&b=5&g=0&id=p86431144783

[glenn1919]

EAF.................https://stockcharts.com/h-sc/ui?s=EAF&p=W&b=5&g=0&id=p86431144783

[glenn1919]

EAF.......................................................https://stockcharts.com/h-sc/ui?s=EAF&p=W&b=5&g=0&id=p86431144783

[RareWare64]

GRAFTECH INTERNATIONAL LTD. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Brookfield Asset Management Inc

[RareWare64]

Harwood Feffer LLP Announces Investigation of GrafTech International Ltd.

[RareWare64]

GRAFTECH INTERNATIONAL LTD. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

[RareWare64]

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of GrafTech International Ltd. of Commencement of an Investigation in Connection With the Fairness of the Sale of the Company to Brookfield Asset Management, Inc.

[RareWare64]

INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of GrafTech International Ltd. (GTI) Over the Proposed Sale of the Company to Brookfield Asset Management, Inc.

NEW YORK, May 19, 2015 /PRNewswire/ -- Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of GrafTech International Ltd. ("GrafTech" or the "Company") (GTI) for potential breaches of fiduciary duties in connection with the sale of the Company to Brookfield Asset Management, Inc. ("Brookfield") for approximately $546 million. The Company's stockholders will only receive $5.05 per share in cash for each share of GrafTech common stock they own. However, at least one analyst has set a price target of $6.00 for the Company's stock.

[RareWare64]

Ofcourse I thought initially this was a stock purchase, not an outright purchase. Hoping the investigations leads Brookfield to pony up some more cash per shareholder. Especially since a target price of over $6 is on the stock.

[RareWare64]

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of GrafTech International Ltd
BALA CYNWYD, Pa.--(BUSINESS WIRE)--

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of GrafTech International Ltd. ("GrafTech” or "the Company") (GTI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Brookfield Asset Management, Inc. (“Brookfield”).

Click here to learn more about the investigation http://brodsky-smith.com/939-gti-graftech-international-ltd.html, or call: 877-534-2590. There is no cost or obligation to you.

Under the terms of the transaction, GrafTech shareholders will receive only $5.05 in cash for each share of GrafTech stock they own. The investigation concerns whether the Board of GrafTech breached their fiduciary duties to shareholders and whether Brookfield is underpaying for GrafTech. The transaction may undervalue GrafTech and would result in a substantial loss for many GrafTech shareholders. For example, an analyst has placed a $6.00 per share price target on GrafTech stock and on January 16, 2014 GrafTech stock traded at $12.97 per share.

If you own shares of GrafTech and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004 by visiting http://brodsky-smith.com/939-gti-graftech-international-ltd.html, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.


View source version on businesswire.com: http://www.businesswire.com/news/home/20150519005484/en/

[RareWare64]

GRAFTECH INTERNATIONAL (GTI) SHAREHOLDER ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of GrafTech International Ltd.

WILMINGTON, Del.--(BUSINESS WIRE)--

Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of GrafTech International Ltd. (GTI) (“GrafTech” or the “Company”) relating to the sale of the Company to an affiliate of Brookfield Asset Management, Inc. (“Brookfield”). On May 18, 2015, the two companies announced the signing of a definitive merger agreement pursuant to which Brookfield will acquire GrafTech in a merger via a tender offer. As a result of the merger, GrafTech shareholders are only anticipated to receive $5.05 per share in cash in exchange for each share of GrafTech.

Our investigation so far has revealed that the consideration GrafTech shareholders are expected to receive is significantly inadequate. While the Company claims that shareholders will receive a “26% premium” for their shares, in reality GrafTech shareholders are only receiving a 2% premium based on Friday’s May 15, 2015 closing price (at $4.95 per share). When compared to yesterday’s $5.05 per share closing stock price, GrafTech shareholders will be receiving virtually no premium at all. Tellingly, analysts at Yahoo! Finance have set a $6.00 per share price target for GrafTech, which is approximately 18.8% more than what GrafTech shareholders are expected to receive.

Andrews & Springer is investigating whether the GrafTech Board of Directors is breaching their fiduciary duties to shareholders and whether GrafTech’s directors have failed to maximize shareholder value.

If you own shares of GrafTech and want to receive additional information and protect your investments free of charge, please visit us at http://www.andrewsspringer.com/cases-investigations/GTI or contact Craig J. Springer, Esq. at [e-mail], or call toll free at 1-800-423-6013. You may also follow us on LinkedIn – www.linkedin.com/company/andrews-&-springer-llc, Twitter – www.twitter.com/AndrewsSpringer or Facebook - www.facebook.com/AndrewsSpringer for future updates.

Andrews & Springer is a boutique securities class action law firm representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty or corporate misconduct. Having formerly defended some of the largest financial institutions in the world, our founding members use their valuable knowledge, experience, and superior skill for the sole purpose of achieving positive results for investors. These traits are the hallmarks of our innovative approach to each case our Firm decides to prosecute. For more information please visit our website at www.andrewsspringer.com. This notice may constitute Attorney Advertising.


View source version on businesswire.com: http://www.businesswire.com/news/home/20150519005813/en/

[RareWare64]

Brookfield is getting a GREAT deal, considering the stock has been trending north looks to continue to do so. Now Brookfield is along for the ride up! $GTI

[RareWare64]

Brookfield plans to buy GrafTech in a tender offer

NEW YORK (AP) -- Brookfield Asset Management Inc. plans to buy graphite manufacturer GrafTech International Ltd. for about $691.8 million in a tender offer.

The Toronto-based asset manager is paying $5.05 per share for GrafTech, which is based in Parma, Ohio. That represents less than a 2 percent premium to the stock's closing price on Friday.

Earlier this month, Brookfield entered a deal with GrafTech to buy $150 million worth of 7 percent convertible preferred shares of GrafTech stock in a private offering.

The tender offer was approved by both company's boards. It will start no later than May 26 and expire on July 7.

"The company believes that Brookfield has an exceptional track record sponsoring public companies in difficult underlying market conditions, including significant knowledge and experience in steel, mining and metals, and other industrial sectors," GrafTech said in a statement.

Shares of GrafTech rose 14 cents, or 2.8 percent, to $5.09 in premarket trading.

[JohnCM]

Looking good here ...

[ivzt]

$5.05 baby ! after hours trading is already up to $4.67!

[ivzt]

Great day for GTI ! It really looks like this will start heading back up.

[ivzt]

Seems like there is a major proxy war and the majority share holders are trying to change over the entire board and executives.

[JohnCM]

What's going on here? Stock recovery?

[basssque]

And at the drop of a hat, we plunge back into the depths below....

[Goodbuddy4863]

Do You know if they have the machines in place to manufacture the grapheme.

They were building a facility somewhere in Ohio about Two Year ago.

The share price kept going down, so I sold them.

They are an excellent play, but I cannot wait.

I am making a wise choice on MMJ in Canada because Medical Marijuana is on the doorstep of every Citizen in Canada if they have it prescribed for them.

No way to lose except for one issue.

Too many competitors could ruin my Game plan.

Good Luck to You and everyone else with all Your Investment dreams.

[JohnCM]

The nice thing about GTI is the floor is in. The bad news is out of the way. The bias is higher.

[Goodbuddy4863]

I would keep an eye on GTI, but not invest in it yet.

The Graphene sales market has no product to sell while CVD[CVV] has.

They produce the machines to produce grapheme..

GTI is an-OK investment for the 25 year Old.

[tpizzazz24]

Invest in the burgers just don't eat them..they'll kill ya lol

[JohnCM]

[Goodbuddy4863]

Not at this time due to my age.




Young Folks should buy some, but I got a better one if anybody is 25 years or Younger.

Put all Your money in MacDonald Hamburgers.

Everybody has to eat and Junk Food is the choice of Young people on the go.

You will die a Millionaire for sure.

MacDonalds pays a handsome dividend 4 times per year.

That is no BULL[check it out].


Note:
Buy the stock, not the product and You will live longer.

[JohnCM]

Not sure graphene is investible.

[Goodbuddy4863]

I remember when John Signorelli was chairman of Iceweb.

The stock was doing great because he was know as an innovator of considerable Cloud Knowledge.

This all was for nothing as he suddenly passed away and IWEB was left without a CEO.

Now, Rob Howe[excellent credentials] has finally won the support of the board of directors and is on the promotion trail.

I do believe what You are saying could very well be true.

Years ago, there was nobody posting on that Board.

Now it is plastered with Penny Stock Players.

They buy Low and sell High.

I do not participate.

Now:

Graftech was highly promoted at one time, but I seen the smoke behind the mirror and sold all of my holdings.

It is still way to early to invest in Graphene unless You are 55 or Younger.

I suggest CVD and GTI in that order.

CVD has to manufacture and deliver the machines before any Graphene can be produced in Mass production.

This is my take.

I am 70 Years old and am too old to catch that Train.

Now Medical marijuana is another exciting subject of which I am heavily invested in.

Save that for another post.

[JohnCM]

Stock promotion

It is not clear whether IceWEB, Inc. (OTCBB:IWEB) has endorsed the pumping of its stock. However, it has been cited that a $12,500 budget has been placed on the table to promote the stock. The newsletter behind the pump is BuyPennyStocks.com. History shows that experiences with BuyPennyStocks.com have not always been good. The promoter is also behind the hype in the stock of another company known as Graphite Corp. (PINK:GRPH). However, questions have been raised about whether Graphite has what it takes to achieve success in the market.

[Goodbuddy4863]

As far as I know, not all of them are Publicly Traded on the Ontario Exchange or the Nasdaq.

Check my post on the Marijuana and stocks company board.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=107985924

[JohnCM]

OK .... back to Graphene.

Looking for a 4th option

CTI CVV CABN

[JohnCM]

"So I am investing in MJ stocks that have an MMPR License from Health Canada[There are only 4 of them presently]."

I did some quick research. I see Tweed.

Some "foreign issue" Tweed

Haven't looked at these yet ...

Aug 25 (Reuters) - Shares of Canadian medical marijuana producers Bedrocan Cannabis Corp and OrganiGram Holdings Inc jumped as they began trading on the TSX Venture exchange on Monday with investors expecting fast-growing demand in the fledgling industry.

What do you have on these?

PharmaCan Capital, a holding company involved with three licensed producers, and Mettrum Ltd are two other marijuana firms that are expected to go public in the coming weeks.

I assume all TSX or US "foreign issue".

I can not find anything on IPO for PharmaCan. Only fund raising.

[JohnCM]

Bedrocan Canada Inc.

Canna Farms Ltd.

CanniMed Ltd.

Delta 9 Bio-Tech Inc.

In The Zone Produce Ltd.

Mettrum Ltd.

MedReleaf Corp.

OrganiGram Inc.

The Peace Naturals Project Inc.

ThunderBird Biomedical Inc.

Tilray

Tweed Inc.

Whistler Medical Marijuana Corp.

[Goodbuddy4863]

CABN is a buy if You are 60 years or Younger[Gotta wait].

Out of all the ones that I looked at CVV is the best one available.

Years ago I predicted Applied Materials would be a Home Run and they were.

They manufactured the machines that made the Chips.

Same thing with CVV. They manufacture the machines that produce Graphene.

https://finance.yahoo.com/echarts?s=CVV+Interactive#%7B%22range%22%3A%222y%22%2C%22scale%22%3A%22linear%22%7D

Too long of a wait for me.

Just found out one of my Kidney arteries is clogged 92%

The other one is working 92%.

I am OK for a few years.

So I am investing in MJ stocks that have an MMPR License from Health Canada[There are only 4 of them presently].

Good Luck all You Folks under 60 Years old.

I got 10 Years on You.

[JohnCM]

Also looking at CVV and CABN